Antivirals get the headlines, but supportive care can make or break an outcome. Dr Taylor closes out the series with the practical side of nursing a cat through FIP treatment and recovery.
FCoV doesn’t stop at the individual cat. Dr Černá looks at what multi-cat households and catteries need to know about managing coronavirus at a population level, not just a patient level.
With multiple antivirals now in circulation and years of real-world use to draw on, Dr Evans covers what the evidence says about the medication options available today — and the controversies that still surround them.
A live panel session where Dr Černá, Dr Knies and Dr Cattin walk through some of their toughest FIP cases — the decisions made under pressure, what worked, and what they’d do differently with hindsight.
Some cats carry lingering effects long after treatment ends. Prof Hartmann reviews the emerging research on ‘long-FIP’ and what it could mean for follow-up care.
Neurological FIP brings its own set of hurdles, from drug penetration to monitoring response. Dr Taylor shares practical strategies for managing these harder cases in general practice.
When signs return after apparent remission, is it relapse or a new infection? Dr Coggins works through how to tell the difference, and what it means for how you approach retreatment.
As alternative antivirals gain traction, Dr Černá shares her clinical experience with molnupiravir and EIDD-1931, and where they fit alongside remdesivir and GS-441524.